Lista de obras - Sylvain Baize - Dominio Público Uruguay

A 40-Month Follow-Up of Ebola Virus Disease Survivors in Guinea (PostEbogui) Reveals Long-Term Detection of Ebola Viral Ribonucleic Acid in Semen and Breast Milk

A single shot against Ebola and Marburg virus

artículo científico publicado en 2005

A vaccine platform against arenaviruses based on a recombinant hyper-attenuated Mopeia virus expressing heterologous glycoproteins

artículo científico publicado en 2018

Arenaviridae exoribonuclease presents genomic RNA edition capacity

Autophagy Promotes Infectious Particle Production of Mopeia and Lassa Viruses

scholarly article by Nicolas Baillet et al published 23 March 2019 in Viruses

Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea

artículo científico publicado en 2017

Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting

scholarly article by E.M. Leroy published in April 2000

Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea

artículo científico publicado en 2017

E3 Ligase ITCH Interacts with the Z Matrix Protein of Lassa and Mopeia Viruses and Is Required for the Release of Infectious Particles

artículo científico publicado en 2019

Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys

artículo científico publicado en 2009

Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates

artículo científico publicado en 2021

Early immune responses accompanying human asymptomatic Ebola infections

artículo científico publicado en 2001

Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa.

artículo científico publicado en 2011

Ebola and Marburg hemorrhagic fever viruses: update on filoviruses

artículo científico

Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues.

artículo científico publicado en 1999

Ebola hemorrhagic fever: a unique efficacious vaccine dose in primates

artículo científico publicado en 2003

Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies

artículo científico publicado en 2018

Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus

artículo científico

Ebola virus: what the practitioner needs to know

artículo científico publicado el 1 de enero de 1998

Ebola: should we consider influenza vaccination?

artículo científico publicado en 2014

Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies

artículo científico publicado en 2016

Emergence of Zaire Ebola Virus Disease in Guinea

artículo científico publicado en 2014

Epidemics of Ebola haemorrhagic fever in Gabon (1994-2002). Epidemiologic aspects and considerations on control measures

artículo científico publicado en 2004

Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea

artículo científico publicado en 2016

Evidence for Ebola virus superantigen activity

artículo científico publicado en 2011

Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response

artículo científico publicado en 2014

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

artículo científico publicado en 2016

Experimental infection of a nonhuman primate with Loa loa induces transient strong immune activation followed by peripheral unresponsiveness of helper T cells.

artículo científico publicado en 1997

Fatal Case of Lassa Fever, Bangolo District, Côte d'Ivoire, 2015

scientific article published on 01 September 2019

Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted

artículo científico publicado en 2017

Human asymptomatic Ebola infection and strong inflammatory response

artículo científico publicado en 2000

Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus

artículo científico publicado en 2011

Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis

artículo científico publicado en 2010

Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection

artículo científico publicado en 2004

Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014.

artículo científico publicado en 2015

Immune parameters and outcomes during Ebola virus disease

Immune responses and Lassa virus infection

artículo científico publicado en 2012

Inflammatory responses in Ebola virus-infected patients.

artículo científico publicado en 2002

Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs

artículo científico publicado en 2017

Isolation and partial molecular characterisation of a strain of Ebola virus during a recent epidemic of viral haemorrhagic fever in Gabon

artículo científico publicado en 1997

Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon

artículo científico publicado en 1997

Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells

scholarly article published by Justine Schaeffer in 2018

Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells

artículo científico publicado en 2004

Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages

artículo científico publicado en 2011

Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study

artículo científico publicado en 2017

NK cells are strongly activated by Lassa and Mopeia virus-infected human macrophages in vitro but do not mediate virus suppression

artículo científico publicado en 2012

New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors

artículo científico publicado en 2016

Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014.

artículo científico publicado en 2014

Non-Pathogenic Mopeia Virus Induces More Robust Activation of Plasmacytoid Dendritic Cells than Lassa Virus

scholarly article by Justine Schaeffer et al published 21 March 2019 in Viruses

Poly(I)-Poly(C12U) but Not Ribavirin Prevents Death in a Hamster Model of Nipah Virus Infection

artículo científico publicado en 2006

Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever

artículo científico publicado en 2014

Rational design of universal immunotherapy for TfR1-tropic arenaviruses

artículo científico publicado en 2020

Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages.

artículo científico publicado en 2006

Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization

artículo científico publicado en 2002

Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement.

artículo científico publicado en 2015

Strengthened Ebola surveillance in France during a major outbreak in West Africa: March 2014-January 2016.

artículo científico publicado en 2017

Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques

artículo científico publicado en 2021

T helper responsiveness in human Loa loa infection; defective specific proliferation and cytokine production by CD4+ T cells from microfilaraemic subjects compared with amicrofilaraemics

The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses

artículo científico publicado en 2014

Towards Broad Protection Against Ebolaviruses ⬇️

artículo científico publicado el 1 de octubre de 2010

Towards deep insight into Ebola virus disease

artículo científico publicado en 2015

Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot

scientific article published on 01 October 2019

Viral zoonoses and emergence: research is just starting

artículo científico publicado en 2015

[Lassa virus and myeloid dendritic cells: a privileged tropism for the suppression of the T lymphocyte response]

artículo científico publicado en 2019

Lista de obras de Sylvain Baize

A 40-Month Follow-Up of Ebola Virus Disease Survivors in Guinea (PostEbogui) Reveals Long-Term Detection of Ebola Viral Ribonucleic Acid in Semen and Breast Milk

A single shot against Ebola and Marburg virus

A vaccine platform against arenaviruses based on a recombinant hyper-attenuated Mopeia virus expressing heterologous glycoproteins

Arenaviridae exoribonuclease presents genomic RNA edition capacity

Autophagy Promotes Infectious Particle Production of Mopeia and Lassa Viruses

Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea

Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting

Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea

E3 Ligase ITCH Interacts with the Z Matrix Protein of Lassa and Mopeia Viruses and Is Required for the Release of Infectious Particles

Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys

Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates

Early immune responses accompanying human asymptomatic Ebola infections

Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa.

Ebola and Marburg hemorrhagic fever viruses: update on filoviruses

Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues.

Ebola hemorrhagic fever: a unique efficacious vaccine dose in primates

Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies

Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus

Ebola virus: what the practitioner needs to know

Ebola: should we consider influenza vaccination?

Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies

Emergence of Zaire Ebola Virus Disease in Guinea

Epidemics of Ebola haemorrhagic fever in Gabon (1994-2002). Epidemiologic aspects and considerations on control measures

Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea

Evidence for Ebola virus superantigen activity

Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Experimental infection of a nonhuman primate with Loa loa induces transient strong immune activation followed by peripheral unresponsiveness of helper T cells.

Fatal Case of Lassa Fever, Bangolo District, Côte d'Ivoire, 2015

Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted

Human asymptomatic Ebola infection and strong inflammatory response

Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus

Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis

Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection

Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014.

Immune parameters and outcomes during Ebola virus disease

Immune responses and Lassa virus infection

Inflammatory responses in Ebola virus-infected patients.

Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs

Isolation and partial molecular characterisation of a strain of Ebola virus during a recent epidemic of viral haemorrhagic fever in Gabon

Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon

Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells

Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells

Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages

Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study

NK cells are strongly activated by Lassa and Mopeia virus-infected human macrophages in vitro but do not mediate virus suppression

New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors

Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014.

Non-Pathogenic Mopeia Virus Induces More Robust Activation of Plasmacytoid Dendritic Cells than Lassa Virus

Poly(I)-Poly(C12U) but Not Ribavirin Prevents Death in a Hamster Model of Nipah Virus Infection

Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever

Rational design of universal immunotherapy for TfR1-tropic arenaviruses

Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages.

Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization

Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement.

Strengthened Ebola surveillance in France during a major outbreak in West Africa: March 2014-January 2016.

Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques

T helper responsiveness in human Loa loa infection; defective specific proliferation and cytokine production by CD4+ T cells from microfilaraemic subjects compared with amicrofilaraemics

The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses

Towards Broad Protection Against Ebolaviruses ⬇️

Towards deep insight into Ebola virus disease

Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot

Viral zoonoses and emergence: research is just starting

[Lassa virus and myeloid dendritic cells: a privileged tropism for the suppression of the T lymphocyte response]